Golden State Equity Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.2K Sell
114
-4,510
-98% -$1.25M 0.07% 155
2026
Q1
$1.37M Buy
4,624
+532
+13% +$158K 0.1% 223
2025
Q4
$1.12M Sell
4,092
-199
-5% -$54.1K 0.18% 128
2025
Q3
$1.16M Buy
4,291
+394
+10% +$107K 0.2% 127
2025
Q2
$1.07M Buy
3,897
+359
+10% +$97.6K 0.2% 126
2025
Q1
$939K Buy
3,538
+70
+2% +$17.3K 0.19% 139
2024
Q4
$805K Buy
3,468
+1,182
+52% +$272K 0.15% 158
2024
Q3
$504K Buy
2,286
+635
+38% +$131K 0.08% 253
2024
Q2
$325K Buy
+1,651
New +$341K 0.07% 302
2023
Q4
$340K Buy
+1,615
New +$345K 0.08% 253

Other funds holding CME

Golden State Equity Partners's CME Position: Q2 2026 in Review

Golden State Equity Partners reduced its CME Group (CME) stake by 98% in Q2 2026, selling an estimated $1.25M and leaving 114 shares worth $25.2K. The position accounts for 0.07% of the portfolio, ranked #155.

Golden State Equity Partners first reported a position in CME in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.37M in Q1 2026. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Golden State Equity Partners held 114 shares of CME Group worth $25.2K as of Q2 2026.
  • Golden State Equity Partners sold 4,510 CME Group shares in Q2 2026, an estimated $1.25M.
  • CME Group made up 0.07% of Golden State Equity Partners's portfolio in Q2 2026, its #155 holding.
  • Golden State Equity Partners first reported a position in CME Group in Q4 2023 and has held it in 10 quarters since.
  • Golden State Equity Partners's CME Group position peaked at $1.37M in Q1 2026.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.